18F-fluorodeoxyglucose (18FDG) PET pulmonary imaging:comparative methodology in COPD patients
Gourab Choudhury(Centre for Inflammation Research), William MacNee(The Queen's Medical Research Institute), Brandon Whitcher(Royal Marsden NHS Foundation Trust), Tim Clark(The Queen's Medical Research Institute), W. Vennart(Pfizer (United States)), Nick Weir(The Queen's Medical Research Institute), Alison Fletcher(University of Edinburgh), Iain Kilty(Pfizer (United States)), Edwin J.R. van Beek(University of Edinburgh), Susie Ferguson(Centre for Inflammation Research), Martin Connell(The Queen's Medical Research Institute), Roberto Rabinovich(Centre for Inflammation Research)
European Respiratory Journal
September 1, 2014
Cited by 0
Related Papers
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
|European Respiratory Journal|2004|4.4k
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
|New England Journal of Medicine|2010|3k
A Resilient, Low-Frequency, Small-World Human Brain Functional Network with Highly Connected Association Cortical Hubs
|Journal of Neuroscience|2006|2.5k
An Introduction to Wavelets and Other Filtering Methods in Finance and Economics
|Elsevier eBooks|2002|1.1k
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k